Companies: 10,795·Total market cap: $144.5T
BioELife Corp.

BioELife Corp.

LITHOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$941
P/E Ratio—
52W High$0.0002
52W Low$0.000001
SEC Filings

BioELife Corp. (LITH) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001396054 · LITH · OTC · as of Jun 8, 2026

Filing snapshot

137
Total Filings
15-12G
Latest Form
2021-07-28
Most Recent
2009
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001396054 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2019-03-28
Fiscal Year End
Mar 28, 2019
Accession No.
0001165527-19-000032
Primary Document
g8684.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001396054 · Accession 0001165527-19-000032

Latest Key Filings

10-QQuarterly Report
Quarterly Report
2019-11-19
View 10-Q on SEC
8-KCurrent Report
FORM 8K SADDLERGIBB
2020-05-06Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
FORM 15-12G
2021-07-28
View
8-KCurrent Report
FORM 8K SADDLERGIBB
2020-05-06
View
8-KCurrent Report
FORM 8K RESPILON
2020-04-17
View
8-KCurrent Report
FORM 8K CONVERTIBLE NOTE
2020-04-07
View
8-KCurrent Report
FORM 8K SADDLER
2020-04-02
View
8-K/ACurrent Report (Amended)
8K COVID EXTENSION
2020-03-31
View
8-KCurrent Report
COVID 8K
2020-03-27
View
8-KCurrent Report
FORM 8K
2020-03-09
View
8-KCurrent Report
FORM 8K CONVERTIBLE NOTE
2020-02-11
View
DEF 14CDEF 14C
DEF 14C NAME CHANGE
2020-02-10
View
8-KCurrent Report
FORM 8K MARKETING AGREEMENT
2020-02-06
View
PRE 14CPRE 14C
PRE 14C - NAME CHANGE
2020-01-29
View
8-KCurrent Report
FORM 8K ASSET PURCHASE AGREEMENT
2020-01-24
View
10-QQuarterly Report
Quarterly Report
2019-11-19
View
NT 10-QNT 10-Q
NT 10-Q
2019-11-13
View
Showing 1–15 of 137 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001396054  |  Exchange: OTC · Healthcare

BioELife Corp. (OTC: LITH) has submitted 137 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2009. As a Healthcare sector company with CIK 0001396054, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is BioELife Corp.'s most comprehensive regulatory disclosure. The most recent BioELife Corp. 10-K was filed on 2019-03-28 for fiscal year ending 2019. Historical LITH 10-K annual reports are available from 2007 through 2019.

Investors researching BioELife Corp. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
PJET SEC Filings →IMVIF SEC Filings →MILC SEC Filings →DMKPQ SEC Filings →OMMH SEC Filings →EFTR SEC Filings →AMHD SEC Filings →MMTC SEC Filings →
→ LITH Financials→ LITH Earnings→ LITH Insider Trades

Frequently Asked Questions

LITH SEC Filings · 8 questions

BioELife Corp. (LITH) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 137 filings and access original documents at no cost. BioELife Corp.'s CIK is 0001396054.

LITH SEC filingsBioELife Corp. SEC documentsfind LITH 10-K